BACKGROUND: Over the last decade novel monoclonal CFTR-specific antibodies have been developed. We here present a paired analysis to detect wild-type and mutant CFTR using Western blot analysis, flow cytometry and confocal microscopy in several cellular expression systems. METHODS: The following CFTR-specific antibodies were used; 217, 432, 450, 570, 769, 596, 660, L12B4 and 24.1. Mutant CFTR was detected in HEK293 cells transiently expressing the mutations; G542X, R1162X, F508del, N1303K, G551D, R117H, A455E. RESULTS: The majority of these antibodies are suitable for most applications tested. Using immunofluorescence, some antibodies can better detect mutant forms of CFTR (F508del and N1303K by mAbs 596 and 769), or display lower aspecific detection by Western blot analysis (mAbs 432, 450, 769 and 596) or immunofluorescence (mAbs 432, 450, 570 and 769). CONCLUSION: Optimal detection of CFTR by monoclonal antibodies depends on CFTR mutation and the specific research application.
BACKGROUND: Over the last decade novel monoclonal CFTR-specific antibodies have been developed. We here present a paired analysis to detect wild-type and mutant CFTR using Western blot analysis, flow cytometry and confocal microscopy in several cellular expression systems. METHODS: The following CFTR-specific antibodies were used; 217, 432, 450, 570, 769, 596, 660, L12B4 and 24.1. Mutant CFTR was detected in HEK293 cells transiently expressing the mutations; G542X, R1162X, F508del, N1303K, G551D, R117H, A455E. RESULTS: The majority of these antibodies are suitable for most applications tested. Using immunofluorescence, some antibodies can better detect mutant forms of CFTR (F508del and N1303K by mAbs 596 and 769), or display lower aspecific detection by Western blot analysis (mAbs 432, 450, 769 and 596) or immunofluorescence (mAbs 432, 450, 570 and 769). CONCLUSION: Optimal detection of CFTR by monoclonal antibodies depends on CFTR mutation and the specific research application.
Authors: Michael G White; Rashmi R Maheshwari; Scott J Anderson; Rolando Berlinguer-Palmini; Claire Jones; Sarah J Richardson; Pavana G Rotti; Sarah L Armour; Yuchun Ding; Natalio Krasnogor; John F Engelhardt; Mike A Gray; Noel G Morgan; James A M Shaw Journal: J Clin Endocrinol Metab Date: 2020-05-01 Impact factor: 5.958
Authors: Chiara De Santi; Elena Fernández Fernández; Rachel Gaul; Sebastian Vencken; Arlene Glasgow; Irene K Oglesby; Killian Hurley; Finn Hawkins; Nilay Mitash; Fangping Mu; Rana Raoof; David C Henshall; Meritxell B Cutrona; Jeremy C Simpson; Brian J Harvey; Barry Linnane; Paul McNally; Sally Ann Cryan; Ronan MacLoughlin; Agnieszka Swiatecka-Urban; Catherine M Greene Journal: Mol Ther Date: 2020-02-06 Impact factor: 11.454
Authors: Nathaniel J Hart; Radhika Aramandla; Gregory Poffenberger; Cody Fayolle; Ariel H Thames; Austin Bautista; Aliya F Spigelman; Jenny Aurielle B Babon; Megan E DeNicola; Prasanna K Dadi; William S Bush; Appakalai N Balamurugan; Marcela Brissova; Chunhua Dai; Nripesh Prasad; Rita Bottino; David A Jacobson; Mitchell L Drumm; Sally C Kent; Patrick E MacDonald; Alvin C Powers Journal: JCI Insight Date: 2018-04-19
Authors: Carleen Mae Sabusap; Disha Joshi; Luba Simhaev; Kathryn E Oliver; Hanoch Senderowitz; Marcel van Willigen; Ineke Braakman; Andras Rab; Eric J Sorscher; Jeong S Hong Journal: J Biol Chem Date: 2021-03-26 Impact factor: 5.486
Authors: Monique M A Verstegen; Floris J M Roos; Ksenia Burka; Helmuth Gehart; Myrthe Jager; Maaike de Wolf; Marcel J C Bijvelds; Hugo R de Jonge; Arif I Ardisasmita; Nick A van Huizen; Henk P Roest; Jeroen de Jonge; Michael Koch; Francesco Pampaloni; Sabine A Fuchs; Imre F Schene; Theo M Luider; Hubert P J van der Doef; Frank A J A Bodewes; Ruben H J de Kleine; Bart Spee; Gert-Jan Kremers; Hans Clevers; Jan N M IJzermans; Edwin Cuppen; Luc J W van der Laan Journal: Sci Rep Date: 2020-12-14 Impact factor: 4.379